Literature DB >> 34036479

Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis.

Mohammed A Alghamdi1,2, Elrashdy M Redwan3,4.   

Abstract

Microbiota is a balanced ecosystem that has important functions to the host health including development, defense, digestion, and absorption of dietary fibers and minerals, vitamin synthesizes, protection, and training the host immune system. On the other hand, its dysbiosis is linked to many human diseases such as rheumatoid arthritis (RA). The RA is an inflammatory autoimmune disorder caused by genetic and environmental factors; microbiota may be considered as a risk environmental factor for it. Citrullination is a post-translation modification (PMT) that converts the amino acid arginine to amino acid citrulline in certain proteins. These citrullinated proteins are recognized as a foreign antigen by the immune system resulting in the upregulation of inflammatory action such as in RA. The current work highlights the effect of both gut and oral microbiota dysbiosis on the development of RA, as well as discusses how the alteration in microbiota composition leads to the overgrowth of some bacterial species that entangled in RA pathogenicity. The evidence suggested that some oral and gut microbial species such as Porphyromonas gingivalis and Prevotella copri, respectively, contribute to RA pathogenesis. During dysbiosis, these bacteria can mediate the citrullination of either human or bacteria proteins to trigger an immune response that leads to the generation of autoantibodies.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Citrullination; Gut dysbiosis; Microbiota; Periodontal disease (PD); Rheumatoid arthritis (RA); Th17

Mesh:

Year:  2021        PMID: 34036479     DOI: 10.1007/s12602-021-09802-7

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  117 in total

Review 1.  Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

Authors:  Li Wen; Andrew Duffy
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

Review 2.  Gut microbiota and liver diseases.

Authors:  Masami Minemura; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.

Authors:  Akihiko Oka; R Balfour Sartor
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

Review 4.  Negative interactions with the microbiota: IBD.

Authors:  Nita H Salzman; Charles L Bevins
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 5.  The microbiome and development of allergic disease.

Authors:  Susan V Lynch; Homer A Boushey
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-04

Review 6.  Current Understanding of Dysbiosis in Disease in Human and Animal Models.

Authors:  Arianna K DeGruttola; Daren Low; Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

7.  Dysbiosis of the gut microbiota in disease.

Authors:  Simon Carding; Kristin Verbeke; Daniel T Vipond; Bernard M Corfe; Lauren J Owen
Journal:  Microb Ecol Health Dis       Date:  2015-02-02

Review 8.  Introduction to the human gut microbiota.

Authors:  Elizabeth Thursby; Nathalie Juge
Journal:  Biochem J       Date:  2017-05-16       Impact factor: 3.857

Review 9.  Human Gut Microbiota and Gastrointestinal Cancer.

Authors:  Changting Meng; Chunmei Bai; Thomas D Brown; Leroy E Hood; Qiang Tian
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-02-21       Impact factor: 7.691

Review 10.  Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota.

Authors:  J Philip Karl; Adrienne M Hatch; Steven M Arcidiacono; Sarah C Pearce; Ida G Pantoja-Feliciano; Laurel A Doherty; Jason W Soares
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

View more
  6 in total

Review 1.  Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis.

Authors:  Mohammed Alghamdi; Sultan Abdulmughni Alamry; Sami M Bahlas; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

2.  Influence of Oral Microbiota on the Presence of IgA Anti-Citrullinated Protein Antibodies in Gingival Crevicular Fluid.

Authors:  Menke J de Smit; Poerwati Soetji Rahajoe; Elisabeth Raveling-Eelsing; Paola Lisotto; Hermie J M Harmsen; Nyoman Kertia; Arjan Vissink; Johanna Westra
Journal:  Front Oral Health       Date:  2022-06-16

Review 3.  The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.

Authors:  Jueyu Hou; Yunjing Tang; Yongjiang Chen; Danian Chen
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

4.  Subgingival Microbiome in Rheumatoid Arthritis Patients with Periodontitis.

Authors:  Yi-Jing Chen; Wei-Chun Hung; Yu-Hsiang Chou; Chern-Hsiung Lai; Po Peng; Pei-Syuan Jhou; Min-Ru Tsai; Jim Jinn-Chyuan Sheu; Jeng-Hsien Yen
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

5.  Molecular Mimicry of the Rheumatoid Arthritis-Related Immunodominant T-Cell Epitope within Type II Collagen (CII260-270) by the Bacterial L-Asparaginase.

Authors:  Dzhemal Moten; Ivanka Teneva; Desislava Apostolova; Tsvetelina Batsalova; Balik Dzhambazov
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

Review 6.  Another Look at the Contribution of Oral Microbiota to the Pathogenesis of Rheumatoid Arthritis: A Narrative Review.

Authors:  Jean-Marie Berthelot; Octave Nadile Bandiaky; Benoit Le Goff; Gilles Amador; Anne-Gaelle Chaux; Assem Soueidan; Frederic Denis
Journal:  Microorganisms       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.